Quick Answer
SANGAMO THERAPEUTICS, INC reported Cash And Cash Equivalents At Carrying Value of $20.95 million for the year ending 2025.
- SANGAMO THERAPEUTICS, INC showed a decrease of -50.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from SANGAMO THERAPEUTICS, INC's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), SANGAMO THERAPEUTICS, INC's Cash And Cash Equivalents At Carrying Value has grown by 7.9%.
- Historical annual values: Fiscal year 2025: $20.95 million | Fiscal year 2024: $41.92 million | Fiscal year 2023: $45.20 million | Fiscal year 2022: $100.44 million | Fiscal year 2021: $178.87 million | Fiscal year 2020: $131.33 million | Fiscal year 2019: $80.43 million | Fiscal year 2018: $140.42 million | Fiscal year 2017: $49.83 million | Fiscal year 2016: $22.06 million | Fiscal year 2015: $69.48 million | Fiscal year 2014: $6.03 million | Fiscal year 2013: $10.19 million | Fiscal year 2012: $21.68 million | Fiscal year 2011: $16.77 million | Fiscal year 2010: $10.78 million | Fiscal year 2009: $21.16 million | Fiscal year 2008: $19.41 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: